InvestorsHub Logo
Followers 33
Posts 2845
Boards Moderated 1
Alias Born 10/24/2015

Re: jondoeuk post# 446

Friday, 09/29/2023 7:53:53 PM

Friday, September 29, 2023 7:53:53 PM

Post# of 550
Also at SITC

Abstract Number 581: Final analysis of 2-THE-TOP: A phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma.

Abstract Number 607: TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study.

Abstract Number 1080: Tumor Treating Fields (TTFields) application induces a pro-inflammatory phenotype in macrophages.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVCR News